Development and Evaluation of SM-ART Intervention (SM-ART)

NCT04694261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-03-03

No results posted yet for this study

Summary

The approach of this intended research is to help pregnant women practice constructive coping and proactive skills that focus on positive adaptation for safe motherhood through our developed intervention.

The objective of this two phases Randomized Control Trial is to develop contextually based "SM-ART" intervention \[Safe Motherhood ART: Accessible Resilience Training\] and evaluate the effectiveness of "SM-ART" intervention in a sample of pregnant women living in low socioeconomic urban areas of Karachi, Pakistan.

It is hypothesized that the SM-ART intervention will enhance resilience and marital harmony and decrease symptoms of depression, anxiety in pregnant women.

Conditions

  • Perinatal Depression
  • Resilience
  • Anxiety
  • Marital Conflict

Interventions

BEHAVIORAL

SM-ART

Intervention is a group based training delivered by midwives on SM-ART module. These training will consist of 6 sessions, one per week for 90 to 120 minutes each.

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER
  • Aga Khan University

    lead OTHER

Principal Investigators

  • Shireen S Bhamani, PhD Student · Aga Khan University School of Nursing & Midwifery

  • Olivier Degomme · University Ghent

  • An-Sofie Van Parys · University Ghent

  • David Arthur · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-06-30
Completion
2021-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04694261 on ClinicalTrials.gov